Michael S. Willett

Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction

L E Diamond, Dennis Earle, R. Rosen et al. · International Journal of Impotence Research · 2004 · 127 citations

Urology, Erectile Dysfunction, Intranasal Pt-141 +6

Prospectus on the Economic Value of Clinical Pharmacy Services

Michael S. Willett, Karen E. Bertch, Darryl S. Rich et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 1989 · 52 citations

Economics, Health Economics, Clinical Pharmacy +5

Pharmacokinetics, Safety, and CCR2/CCR5 Antagonist Activity of Cenicriviroc in Participants With Mild or Moderate Hepatic Impairment

Éric Lefebvre, Mildred D. Gottwald, Kenneth C. Lasseter et al. · Clinical and Translational Science · 2016 · 51 citations · Full text

Clinical Pharmacokinetics and Drug‐Drug Interaction Potential for Coadministered SCY‐078, an Oral Fungicidal Glucan Synthase Inhibitor, and Tacrolimus

Stephen A. Wring, Gail Murphy, George Atiee et al. · Clinical Pharmacology in Drug Development · 2018 · 46 citations · Full text

Lack of Impact by SCY‐078, a First‐in‐Class Oral Fungicidal Glucan Synthase Inhibitor, on the Pharmacokinetics of Rosiglitazone, a Substrate for CYP450 2C8, Supports the Low Risk for Clinically Relevant Metabolic Drug‐Drug Interactions

Stephen A. Wring, Gail Murphy, George Atiee et al. · The Journal of Clinical Pharmacology · 2018 · 38 citations · Full text